Delcourt Cécile

Stuart Kelsey V, de Vries Victor A, Schuster Alexander K, Yu Yu, van der Heide Frank C T, Delcourt Cécile et al.

European glaucoma prevalence is 2.99%, with 56.4% undiagnosed. This burden of 12.3 million will increase by >1 million by 2050, highlighting the urgent need for improved early detection.

Larsen Petra P, Féart Catherine, Pais de Barros Jean-Paul, Gayraud Laure, Delyfer Marie-Noëlle, Korobelnik Jean-François et al.

This study linked higher blood endotoxins (LPS) to thinner baseline retinal nerve fiber layers, suggesting gut microbiota involvement in early optic nerve neurodegeneration and retinal health.

Vergroesen Joëlle E, Schuster Alexander K, Stuart Kelsey V, Asefa Nigus G, Cougnard-Grégoire Audrey, Delcourt Cécile et al.

This study found calcium channel blockers linked to higher glaucoma prevalence, while systemic beta-blockers lowered IOP. This is clinically relevant as many glaucoma patients use these medications.

Creuzot-Garcher Catherine, Binquet Christine, Daniel Sandrine, Bretillon Lionel, Acar Nyiazi, de Lazzer Aurélie et al.

The Montrachet Study found low visual impairment in elderly individuals (75+), increasing with age. This helps estimate eye disease prevalence and explore links to systemic conditions in this population.

Rougier Marie-Bénédicte, Korobelnik Jean-François, Malet Florence, Schweitzer Cédric, Delyfer Marie-Noëlle, Dartigues Jean-François et al.

This study found elderly RNFL thickness decreases with age, especially supero- and inferotemporally, and is often higher in women. This highlights the need to consider age, sex, and axial length when interpreting OCTs.